Gastroenterology and Hepatology

Kansas City, Missouri 64131

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Hepatitis C, Irritable Bowel Syndrome

Studies at this site

• Study to Assess the Efficacy and Safety of Rifaximin Administered BID in the Treatment of Patients With Diarrhea-Associated Irritable Bowel Syndrome — Completed
• Study of FK788 in Subjects With Chronic Hepatitis C Virus Infection — Completed
• Remission in Subjects With Crohn's Disease, 1 Year Phase — Completed
• Remission in Subjects With Crohn's Disease, Open Label Extension — Completed
• A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease — Completed